Cited by 161Amyotrophic Lateral Sclerosis ResearchHereditary Neurological DisordersAlzheimer's disease research and treatments

Progranulin genetic variability contributes to amyotrophic lateral sclerosis

Sleegers, K., Brouwers, N., Maurer-Stroh, S., van Es, M. A., Damme, P. Van, van Vught, P.W.J., van der Zee, J., Serneels, S. +9 more·2008·Neurology

Abstract

OBJECTIVES: Null mutations in progranulin (PGRN) cause ubiquitin-positive frontotemporal dementia (FTD) linked to chromosome 17q21 (FTDU-17). Here we examined PGRN genetic variability in amyotrophic lateral sclerosis (ALS), a neurodegenerative motor neuron disease that overlaps with FTD at a clinical, pathologic, and epidemiologic level. METHODS: We sequenced all exons, exon-intron boundaries, and 5' and 3' regulatory regions of PGRN in a Belgian sample of 230 patients with ALS. The frequency of observed genetic variants was determined in 436 healthy control individuals. The contribution of eight frequent polymorphisms to ALS risk, onset age, and survival was assessed in an association study in the Belgian sample and a replication series of 308 Dutch patients with ALS and 345 Dutch controls. RESULTS: In patients with ALS we identified 11 mutations, 5 of which were predicted to affect PGRN protein sequence or levels (four missense mutations and one 5' regulatory variant). Moreover, common variants (rs9897526, rs34424835, and rs850713) and haplotypes were significantly associated with a reduction in age at onset and a shorter survival after onset of ALS in both the Belgian and the Dutch studies. CONCLUSION: PGRN acts as a modifier of the course of disease in patients with amyotrophic lateral sclerosis, through earlier onset and shorter survival.

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000289191.54852.75

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Five progranulin mutations (four missense and one 5′ regulatory variant) are linked to earlier ALS onset and shorter survival after onset.

    “Five progranulin mutations (four missense and one 5′ regulatory variant) are associated with reduction in age at onset and shorter survival after onset of ALS”

    From Microglia in neurodegeneration (2018) · cites this paper as [146]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sleegers, K., Brouwers, N., Maurer-Stroh, S., van Es, M. A., Damme, P. V., van Vught, P. W. J., van der Zee, J., Serneels, S., Pooter, T. D., Van den Broeck, M., Cruts, M., Schymkowitz, J., Jonghe, P. D., Rousseau, F., van den Berg, L. H., Robberecht, W., & Broeckhoven, C. V.
Affiliations
  • University of Antwerp (BE)
  • From the Neurodegenerative Brain Diseases Group (K.S., N.B., J.v.d.Z., S.S., T.D.P., M.V.d.B., M.C., C.V.B.) and Neurogenetics Group (P.D.J.), Department of Molecular Genetics, and SWITCH Laboratory (S.M.-S., J.S., F.R.) VIB, University of Antwerp (K.S., N.B., J.v.d.Z., S.S., T.D.P., M.V.d.B., M.C., P.D.J., C.V.B.), Antwerpen; University Brussels (VUB) (S.M.-S., J.S., F.R.); Department of Neurology (M.A.v.E., P.W.J.v.V., L.H.v.d.B.), Rudolf Magnus Institute of Neuroscience, University Medical Center...
Venue
Neurology
Published
2008-07-22
Volume
71
Issue
4
Pages
253-259
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W1995715453
Cited by
161
References
40
Citations by year
2026: 2 · 2025: 7 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 5 · 2018: 7 · 2017: 3 · 2016: 7 · 2015: 13 · 2014: 7 · 2013: 11 · 2012: 19
FWCI
12.59
Type
journal article
Language
en
Open access
closed
Locations
  • Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
progranulin, amyotrophic lateral sclerosis, missense mutations, haplotypes, age of onset, clinical course, frontotemporal dementia, 17q21, genetic association
MeSH terms
Progranulins, Adult, Aged, Amyotrophic Lateral Sclerosis, Belgium, Dementia, DNA Mutational Analysis, Female, Genetic Markers, Genetic Testing, Genotype, Haplotypes, Humans, Male, Middle Aged, Mutation, Netherlands, Polymorphism, Genetic, Genetic Variation, Survival Rate, Age of Onset, Genetic Predisposition to Disease, Mutation, Missense, Intercellular Signaling Peptides and Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review